Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	2.69e-07	372	80	11	GO:0061630
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	5.25e-07	398	80	11	GO:0061659
GeneOntologyMolecularFunction	zinc ion binding	USP44 TRAF6 TIMP2 TRIM75 MARCHF8 ESR1 ESR2 MARCHF2 MMP23B NFX1 TRIM77 SKI TRIM27 MARCHF1 CXXC1	2.16e-06	891	80	15	GO:0008270
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	2.82e-06	473	80	11	GO:0004842
GeneOntologyMolecularFunction	transition metal ion binding	USP44 TRAF6 TIMP2 CYP4Z1 TRIM75 MARCHF8 ESR1 ESR2 MARCHF2 MMP23B NFX1 CYP4X1 TRIM77 SKI TRIM27 MARCHF1 CXXC1	3.78e-06	1189	80	17	GO:0046914
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	6.00e-06	512	80	11	GO:0019787
GeneOntologyMolecularFunction	aminoacyltransferase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	8.62e-06	532	80	11	GO:0016755
GeneOntologyMolecularFunction	nuclear estrogen receptor activity	ESR1 ESR2	9.46e-05	4	80	2	GO:0030284
GeneOntologyMolecularFunction	anandamide 14,15 epoxidase activity	CYP4Z1 CYP4X1	2.35e-04	6	80	2	GO:0062189
GeneOntologyMolecularFunction	anandamide epoxidase activity	CYP4Z1 CYP4X1	2.35e-04	6	80	2	GO:0062186
GeneOntologyMolecularFunction	acyltransferase activity	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	2.56e-04	775	80	11	GO:0016746
GeneOntologyMolecularFunction	pore-forming activity	DEFA1 DEFA3	6.99e-04	10	80	2	GO:0140911
GeneOntologyMolecularFunction	estrogen response element binding	ESR1 ESR2	8.52e-04	11	80	2	GO:0034056
GeneOntologyBiologicalProcess	post-translational protein modification	CBLL1 USP44 CTU2 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 USP9Y TRIM27 ZNF598 MARCHF1 ZC3HAV1	1.63e-05	1074	81	15	GO:0043687
GeneOntologyBiologicalProcess	motor neuron migration	CELSR1 CELSR3 CELSR2	2.57e-05	15	81	3	GO:0097475
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	CBLL1 USP44 CTU2 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 USP9Y TRIM27 ZNF598 MARCHF1	3.49e-05	1009	81	14	GO:0070647
GeneOntologyBiologicalProcess	protein modification by small protein conjugation	CBLL1 USP44 CTU2 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	4.22e-05	893	81	13	GO:0032446
GeneOntologyBiologicalProcess	defense response to virus	DEFA1 DEFA3 USP44 TRAF6 MARCHF2 TRIM27 DICER1 ZC3HAV1	5.91e-05	342	81	8	GO:0051607
GeneOntologyBiologicalProcess	protein ubiquitination	CBLL1 USP44 TRAF6 TRIM75 MARCHF8 MARCHF2 NFX1 TRIM77 MARVELD3 TRIM27 ZNF598 MARCHF1	7.35e-05	811	81	12	GO:0016567
GeneOntologyBiologicalProcess	estrogen receptor signaling pathway	DEFA1 DEFA3 ESR1 ESR2	7.44e-05	57	81	4	GO:0030520
GeneOntologyBiologicalProcess	neural tube development	CELSR1 TRAF6 SMO SKI WDPCP SEMA4C	1.44e-04	202	81	6	GO:0021915
GeneOntologyBiologicalProcess	calcium activated phospholipid scrambling	ANO4 ANO3	1.51e-04	5	81	2	GO:0061588
GeneOntologyBiologicalProcess	calcium activated phosphatidylcholine scrambling	ANO4 ANO3	1.51e-04	5	81	2	GO:0061590
GeneOntologyBiologicalProcess	calcium activated galactosylceramide scrambling	ANO4 ANO3	1.51e-04	5	81	2	GO:0061591
GeneOntologyBiologicalProcess	disruption of plasma membrane integrity in another organism	DEFA1 DEFA3	2.26e-04	6	81	2	GO:0051673
GeneOntologyBiologicalProcess	disruption of cellular anatomical structure in another organism	DEFA1 DEFA3	2.26e-04	6	81	2	GO:0140975
GeneOntologyBiologicalProcess	non-canonical Wnt signaling pathway	CELSR1 CELSR3 CELSR2 FZD10	2.40e-04	77	81	4	GO:0035567
GeneOntologyBiologicalProcess	response to virus	DEFA1 DEFA3 USP44 TRAF6 MARCHF2 TRIM27 DICER1 ZC3HAV1	2.63e-04	425	81	8	GO:0009615
GeneOntologyBiologicalProcess	innate immune response	DEFA1 IL34 DEFA3 USP44 TRAF6 ESR1 MARCHF2 UMOD TRIM77 TRIM27 IL18RAP NPLOC4 ZC3HAV1	3.13e-04	1092	81	13	GO:0045087
GeneOntologyBiologicalProcess	negative regulation of MHC class II biosynthetic process	MARCHF8 NFX1	3.16e-04	7	81	2	GO:0045347
GeneOntologyBiologicalProcess	defense response to other organism	DEFA1 IL34 DEFA3 USP44 TRAF6 STAB2 ESR1 MARCHF2 UMOD TRIM77 TRIM27 IL18RAP DICER1 NPLOC4 ZC3HAV1	3.39e-04	1407	81	15	GO:0098542
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class II	TRAF6 MARCHF8 MARCHF1	3.79e-04	36	81	3	GO:0002495
GeneOntologyBiologicalProcess	Sertoli cell proliferation	ESR1 ESR2	4.20e-04	8	81	2	GO:0060011
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	TRAF6 MARCHF8 MARCHF1	4.46e-04	38	81	3	GO:0002504
GeneOntologyBiologicalProcess	defense response to symbiont	DEFA1 IL34 DEFA3 USP44 TRAF6 ESR1 MARCHF2 UMOD TRIM77 TRIM27 IL18RAP DICER1 NPLOC4 ZC3HAV1	4.46e-04	1286	81	14	GO:0140546
GeneOntologyBiologicalProcess	negative regulation of Schwann cell proliferation	SKI DICER1	5.39e-04	9	81	2	GO:0010626
GeneOntologyCellularComponent	Golgi lumen	DEFA1 DEFA3 UMOD GPC5 MUC5AC	6.97e-05	109	82	5	GO:0005796
HumanPheno	Neuroepithelial neoplasm	MMP23B SMO SKI DICER1 SDHB	4.48e-05	92	23	5	HP:0030063
HumanPheno	Neuroectodermal neoplasm	MMP23B SMO SKI DICER1 SDHB	4.97e-05	94	23	5	HP:0030061
HumanPheno	Nervous tissue neoplasm	MMP23B SMO SKI DICER1 SDHB	4.97e-05	94	23	5	HP:0030060
HumanPheno	Malignant neoplasm of the central nervous system	MMP23B SMO SKI DICER1 SDHB	6.39e-05	99	23	5	HP:0100836
HumanPheno	Neoplasm of the central nervous system	MMP23B SMO SKI DICER1 WDPCP SDHB	1.03e-04	178	23	6	HP:0100006
HumanPheno	Decreased urinary urate	UMOD MOCS1	1.16e-04	4	23	2	HP:0011935
HumanPheno	Neoplasm of the nervous system	MMP23B SMO SKI DICER1 WDPCP SDHB	1.70e-04	195	23	6	HP:0004375
HumanPheno	Primitive neuroectodermal tumor	MMP23B SKI DICER1 SDHB	2.01e-04	67	23	4	HP:0030065
Domain	-	CBLL1 USP44 TRAF6 MARCHF8 MARCHF2 ZFYVE21 SCAF11 TRIM77 TRIM27 ZNF598 MARCHF1 CXXC1	5.07e-07	449	81	12	3.30.40.10
Domain	Znf_RING/FYVE/PHD	CBLL1 USP44 TRAF6 MARCHF8 MARCHF2 ZFYVE21 SCAF11 TRIM77 TRIM27 ZNF598 MARCHF1 CXXC1	6.40e-07	459	81	12	IPR013083
Domain	Znf_RING	CBLL1 TRAF6 MARCHF8 MARCHF2 NFX1 SCAF11 TRIM77 TRIM27 ZNF598 MARCHF1	1.43e-06	326	81	10	IPR001841
Domain	MARCH-like	MARCHF8 MARCHF2 MARCHF1	4.33e-06	8	81	3	IPR033275
Domain	GPCR_2_secretin-like	CELSR1 CELSR3 CELSR2 FZD10 SMO	6.13e-06	60	81	5	IPR000832
Domain	GPCR_2-like	CELSR1 CELSR3 CELSR2 FZD10 SMO	6.13e-06	60	81	5	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	CELSR1 CELSR3 CELSR2 FZD10 SMO	6.66e-06	61	81	5	PS50261
Domain	EGF_LAM_2	CELSR1 STAB2 CELSR3 CELSR2	8.26e-06	30	81	4	PS50027
Domain	EGF_LAM_1	CELSR1 STAB2 CELSR3 CELSR2	8.26e-06	30	81	4	PS01248
Domain	RINGv	MARCHF8 MARCHF2 MARCHF1	1.26e-05	11	81	3	PF12906
Domain	GAIN_dom_N	CELSR1 CELSR3 CELSR2	1.26e-05	11	81	3	IPR032471
Domain	ZF_RING_CH	MARCHF8 MARCHF2 MARCHF1	1.26e-05	11	81	3	PS51292
Domain	GAIN	CELSR1 CELSR3 CELSR2	1.26e-05	11	81	3	PF16489
Domain	EGF_CA	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	1.49e-05	122	81	6	SM00179
Domain	EGF_Lam	CELSR1 STAB2 CELSR3 CELSR2	1.55e-05	35	81	4	SM00180
Domain	EGF-like_Ca-bd_dom	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	1.64e-05	124	81	6	IPR001881
Domain	EGF	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	1.80e-05	126	81	6	PF00008
Domain	LAM_G_DOMAIN	CELSR1 CELSR3 CELSR2 SLIT3	2.17e-05	38	81	4	PS50025
Domain	Laminin_EGF	CELSR1 STAB2 CELSR3 CELSR2	2.17e-05	38	81	4	IPR002049
Domain	Laminin_G_2	CELSR1 CELSR3 CELSR2 SLIT3	2.66e-05	40	81	4	PF02210
Domain	LamG	CELSR1 CELSR3 CELSR2 SLIT3	3.91e-05	44	81	4	SM00282
Domain	Znf_RING-CH	MARCHF8 MARCHF2 MARCHF1	5.11e-05	17	81	3	IPR011016
Domain	RINGv	MARCHF8 MARCHF2 MARCHF1	5.11e-05	17	81	3	SM00744
Domain	zf-C3HC4	TRAF6 MARCHF8 MARCHF2 NFX1 TRIM77 TRIM27 MARCHF1	5.17e-05	223	81	7	PF00097
Domain	EGF-type_Asp/Asn_hydroxyl_site	CELSR1 CELSR3 CELSR2 SLIT3 UMOD	9.74e-05	106	81	5	IPR000152
Domain	Znf_C3HC4_RING-type	TRAF6 MARCHF8 MARCHF2 TRIM77 TRIM27 MARCHF1	1.02e-04	172	81	6	IPR018957
Domain	Laminin_G	CELSR1 CELSR3 CELSR2 SLIT3	1.17e-04	58	81	4	IPR001791
Domain	HormR	CELSR1 CELSR3 CELSR2	1.69e-04	25	81	3	SM00008
Domain	Defensin_propep	DEFA1 DEFA3	1.84e-04	5	81	2	PF00879
Domain	Alpha-defensin	DEFA1 DEFA3	1.84e-04	5	81	2	IPR006081
Domain	Defensin_1	DEFA1 DEFA3	1.84e-04	5	81	2	PF00323
Domain	Alpha-defensin_pro	DEFA1 DEFA3	1.84e-04	5	81	2	IPR016327
Domain	Oest_rcpt/oest-rel_rcp	ESR1 ESR2	1.84e-04	5	81	2	IPR024178
Domain	DEFENSIN	DEFA1 DEFA3	1.84e-04	5	81	2	PS00269
Domain	Defensin_propep	DEFA1 DEFA3	1.84e-04	5	81	2	IPR002366
Domain	HRM	CELSR1 CELSR3 CELSR2	2.38e-04	28	81	3	PF02793
Domain	ZF_RING_1	CBLL1 TRAF6 NFX1 SCAF11 TRIM77 TRIM27 ZNF598	2.69e-04	291	81	7	PS00518
Domain	ZF_RING_2	CBLL1 TRAF6 NFX1 SCAF11 TRIM77 TRIM27 ZNF598	3.11e-04	298	81	7	PS50089
Domain	RING	CBLL1 TRAF6 NFX1 SCAF11 TRIM77 TRIM27 ZNF598	3.58e-04	305	81	7	SM00184
Domain	ConA-like_dom	CELSR1 CELSR3 CELSR2 SLIT3 TRIM77 TRIM27	3.79e-04	219	81	6	IPR013320
Domain	Anoct_dimer	ANO4 ANO3	3.85e-04	7	81	2	PF16178
Domain	Anoct_dimer	ANO4 ANO3	3.85e-04	7	81	2	IPR032394
Domain	GPS	CELSR1 CELSR3 CELSR2	4.27e-04	34	81	3	SM00303
Domain	GPS	CELSR1 CELSR3 CELSR2	4.65e-04	35	81	3	PF01825
Domain	Laminin_EGF	CELSR1 CELSR3 CELSR2	4.65e-04	35	81	3	PF00053
Domain	GPS	CELSR1 CELSR3 CELSR2	5.06e-04	36	81	3	PS50221
Domain	Defensin_beta/alpha	DEFA1 DEFA3	5.11e-04	8	81	2	IPR006080
Domain	DEFSN	DEFA1 DEFA3	5.11e-04	8	81	2	SM00048
Domain	GPS	CELSR1 CELSR3 CELSR2	5.49e-04	37	81	3	IPR000203
Domain	EGF_3	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	5.50e-04	235	81	6	PS50026
Domain	EGF	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	5.50e-04	235	81	6	SM00181
Domain	Growth_fac_rcpt_	CELSR1 STAB2 CELSR2 SLIT3 UMOD	5.86e-04	156	81	5	IPR009030
Domain	R3H	NFX1 NKRF	6.56e-04	9	81	2	SM00393
Domain	G_PROTEIN_RECEP_F2_1	CELSR1 CELSR3 CELSR2	6.92e-04	40	81	3	PS00649
Domain	GPCR_2_extracellular_dom	CELSR1 CELSR3 CELSR2	6.92e-04	40	81	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_3	CELSR1 CELSR3 CELSR2	6.92e-04	40	81	3	PS50227
Domain	Znf_RING_CS	CBLL1 TRAF6 SCAF11 TRIM77 TRIM27	7.15e-04	163	81	5	IPR017907
Domain	EGF-like_dom	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	7.45e-04	249	81	6	IPR000742
Domain	-	CELSR1 CELSR3 CELSR2 SLIT3	7.75e-04	95	81	4	2.60.120.200
Domain	Anoctamin	ANO4 ANO3	8.17e-04	10	81	2	PF04547
Domain	Anoctamin	ANO4 ANO3	8.17e-04	10	81	2	IPR007632
Domain	EGF_1	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	8.43e-04	255	81	6	PS00022
Domain	ASX_HYDROXYL	CELSR1 CELSR3 CELSR2 UMOD	9.39e-04	100	81	4	PS00010
Domain	EGF-like_CS	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	9.51e-04	261	81	6	IPR013032
Domain	-	STAB2 UMOD	9.96e-04	11	81	2	2.40.155.10
Domain	GFP-like	STAB2 UMOD	9.96e-04	11	81	2	IPR023413
Domain	R3H	NFX1 NKRF	9.96e-04	11	81	2	PS51061
Domain	Frizzled	FZD10 SMO	9.96e-04	11	81	2	IPR000539
Domain	R3H	NFX1 NKRF	9.96e-04	11	81	2	PF01424
Domain	Frizzled	FZD10 SMO	9.96e-04	11	81	2	PF01534
Domain	-	NFX1 NKRF	9.96e-04	11	81	2	3.30.1370.50
Domain	R3H_dom	NFX1 NKRF	9.96e-04	11	81	2	IPR001374
Domain	Frizzled	FZD10 SMO	9.96e-04	11	81	2	SM01330
Domain	EGF_2	CELSR1 STAB2 CELSR3 CELSR2 SLIT3 UMOD	1.03e-03	265	81	6	PS01186
Domain	EGF_3	STAB2 UMOD	1.19e-03	12	81	2	PF12947
Domain	TIL	BMPER MUC5AC	1.19e-03	12	81	2	PF01826
Domain	EGF_dom	STAB2 UMOD	1.19e-03	12	81	2	IPR024731
Domain	C8	BMPER MUC5AC	1.19e-03	12	81	2	PF08742
Domain	G_PROTEIN_RECEP_F2_2	CELSR1 CELSR3 CELSR2	1.33e-03	50	81	3	PS00650
Domain	7tm_2	CELSR1 CELSR3 CELSR2	1.33e-03	50	81	3	PF00002
Domain	Unchr_dom_Cys-rich	BMPER MUC5AC	1.40e-03	13	81	2	IPR014853
Domain	C8	BMPER MUC5AC	1.40e-03	13	81	2	SM00832
Domain	ZP_1	ZPLD1 UMOD	1.63e-03	14	81	2	PS00682
Domain	TIL_dom	BMPER MUC5AC	1.63e-03	14	81	2	IPR002919
Domain	ZP_2	ZPLD1 UMOD	1.63e-03	14	81	2	PS51034
Domain	ZP	ZPLD1 UMOD	1.88e-03	15	81	2	SM00241
Domain	VWD	BMPER MUC5AC	2.14e-03	16	81	2	SM00216
Domain	VWF_type-D	BMPER MUC5AC	2.14e-03	16	81	2	IPR001846
Domain	VWFD	BMPER MUC5AC	2.14e-03	16	81	2	PS51233
Domain	VWD	BMPER MUC5AC	2.14e-03	16	81	2	PF00094
Domain	Frizzled/SFRP	FZD10 SMO	2.14e-03	16	81	2	IPR015526
Domain	ZP_dom	ZPLD1 UMOD	2.42e-03	17	81	2	IPR001507
Domain	Zona_pellucida	ZPLD1 UMOD	2.42e-03	17	81	2	PF00100
Domain	CTCK_1	SLIT3 MUC5AC	2.72e-03	18	81	2	PS01185
Domain	DSRM	DICER1 NKRF	3.03e-03	19	81	2	SM00358
Domain	dsrm	DICER1 NKRF	3.36e-03	20	81	2	PF00035
Domain	FRI	FZD10 SMO	3.36e-03	20	81	2	SM00063
Domain	-	FZD10 SMO	3.70e-03	21	81	2	1.10.2000.10
Domain	CT	SLIT3 MUC5AC	4.06e-03	22	81	2	SM00041
Pubmed	Human MARCH1, 2, and 8 block Ebola virus envelope glycoprotein cleavage via targeting furin P domain.	MARCHF8 MARCHF2 MARCHF1	1.26e-08	3	82	3	38299743
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR1 CELSR3 CELSR2	1.26e-08	3	82	3	11677057
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR1 CELSR3 CELSR2	5.04e-08	4	82	3	37224017
Pubmed	Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms.	ESR1 ESR2 TRPV6	5.04e-08	4	82	3	14584880
Pubmed	Developmental expression profiles of Celsr (Flamingo) genes in the mouse.	CELSR1 CELSR3 CELSR2	5.04e-08	4	82	3	11850187
Pubmed	Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues.	CELSR1 CELSR3 CELSR2	4.39e-07	7	82	3	17937400
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	CELSR3 CELSR2 SLIT3	1.05e-06	9	82	3	9693030
Pubmed	A dual role for planar cell polarity genes in ciliated cells.	CELSR1 CELSR3 CELSR2	2.06e-06	11	82	3	25024228
Pubmed	Differential expression of the seven-pass transmembrane cadherin genes Celsr1-3 and distribution of the Celsr2 protein during mouse development.	CELSR1 CELSR3 CELSR2	2.74e-06	12	82	3	11891983
Pubmed	Atypical cadherins Celsr1-3 differentially regulate migration of facial branchiomotor neurons in mice.	CELSR1 CELSR3 CELSR2	2.74e-06	12	82	3	20631168
Pubmed	Mesenchymal Vangl1 and Vangl2 facilitate airway elongation and widening independently of the planar cell polarity complex.	CELSR1 CELSR3 CELSR2	4.51e-06	14	82	3	39225402
Pubmed	Malformation of Tear Ducts Underlies the Epiphora and Precocious Eyelid Opening in Prickle 1 Mutant Mice: Genetic Implications for Tear Duct Genesis.	CELSR1 CELSR3 CELSR2 FZD10	4.74e-06	47	82	4	33141892
Pubmed	Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.	ESR1 ESR2	5.49e-06	2	82	2	29655286
Pubmed	CpG methylation of the ERalpha and ERbeta genes in breast cancer.	ESR1 ESR2	5.49e-06	2	82	2	15254780
Pubmed	Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.	ESR1 ESR2	5.49e-06	2	82	2	22776819
Pubmed	Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro.	DEFA1 DEFA3	5.49e-06	2	82	2	12871849
Pubmed	Alleles and haplotypes of the estrogen receptor alpha gene are associated with an increased risk of spontaneous abortion.	ESR1 ESR2	5.49e-06	2	82	2	19200973
Pubmed	Estrogen receptor alpha and beta polymorphisms are associated with semen quality.	ESR1 ESR2	5.49e-06	2	82	2	19959825
Pubmed	Role of estrogen receptor α and β in preserving hippocampal function during aging.	ESR1 ESR2	5.49e-06	2	82	2	23392694
Pubmed	Effects of ERβ and ERα on OVX-induced changes in adiposity and insulin resistance.	ESR1 ESR2	5.49e-06	2	82	2	32053493
Pubmed	Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.	ESR1 ESR2	5.49e-06	2	82	2	11826769
Pubmed	Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice.	ESR1 ESR2	5.49e-06	2	82	2	19285805
Pubmed	Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse.	ESR1 ESR2	5.49e-06	2	82	2	22038234
Pubmed	Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta.	ESR1 ESR2	5.49e-06	2	82	2	20961965
Pubmed	Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population.	ESR1 ESR2	5.49e-06	2	82	2	15193490
Pubmed	Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo.	ESR1 ESR2	5.49e-06	2	82	2	33159119
Pubmed	Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells.	ESR1 ESR2	5.49e-06	2	82	2	16118406
Pubmed	Expression of aromatase and estrogen receptors in lumbar motoneurons of mice.	ESR1 ESR2	5.49e-06	2	82	2	28501695
Pubmed	Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.	ESR1 ESR2	5.49e-06	2	82	2	20372779
Pubmed	Human permanent tooth sizes are associated with genes encoding oestrogen receptors.	ESR1 ESR2	5.49e-06	2	82	2	32985343
Pubmed	The distribution of cells containing estrogen receptor-alpha (ERalpha) and ERbeta messenger ribonucleic acid in the preoptic area and hypothalamus of the sheep: comparison of males and females.	ESR1 ESR2	5.49e-06	2	82	2	10919284
Pubmed	Estrogen Receptor Expression in Pancreatic Adenocarcinoma: Time to Reconsider Evidence.	ESR1 ESR2	5.49e-06	2	82	2	34860807
Pubmed	Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues.	ESR1 ESR2	5.49e-06	2	82	2	11162937
Pubmed	Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?	ESR1 ESR2	5.49e-06	2	82	2	16735942
Pubmed	Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.	ESR1 ESR2	5.49e-06	2	82	2	16880783
Pubmed	Endogenous estradiol and its association with estrogen receptor gene polymorphisms.	ESR1 ESR2	5.49e-06	2	82	2	16949384
Pubmed	Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.	ESR1 ESR2	5.49e-06	2	82	2	17889406
Pubmed	Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN).	ESR1 ESR2	5.49e-06	2	82	2	16949390
Pubmed	The association of bone mineral density with estrogen receptor gene polymorphisms.	ESR1 ESR2	5.49e-06	2	82	2	16949392
Pubmed	Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta.	ESR1 ESR2	5.49e-06	2	82	2	24654233
Pubmed	Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation.	ESR1 ESR2	5.49e-06	2	82	2	30863326
Pubmed	Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration.	ESR1 ESR2	5.49e-06	2	82	2	29367057
Pubmed	Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.	ESR1 ESR2	5.49e-06	2	82	2	17924141
Pubmed	Differential expression of estrogen receptor α and β isoforms in multiple and solitary leiomyomas.	ESR1 ESR2	5.49e-06	2	82	2	26529545
Pubmed	Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.	ESR1 ESR2	5.49e-06	2	82	2	32853964
Pubmed	Localization of estrogen and androgen receptors in male reproductive tissues of mice and rats.	ESR1 ESR2	5.49e-06	2	82	2	15278948
Pubmed	Pregnancy and oestrogen regulate sinoatrial node calcium homeostasis and accelerate pacemaking.	ESR1 ESR2	5.49e-06	2	82	2	29800268
Pubmed	The differential fate of mesonephric tubular-derived efferent ductules in estrogen receptor-alpha knockout versus wild-type female mice.	ESR1 ESR2	5.49e-06	2	82	2	11014235
Pubmed	17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.	ESR1 ESR2	5.49e-06	2	82	2	19003958
Pubmed	Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.	ESR1 ESR2	5.49e-06	2	82	2	24884830
Pubmed	Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.	ESR1 ESR2	5.49e-06	2	82	2	18955141
Pubmed	Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.	ESR1 ESR2	5.49e-06	2	82	2	15374829
Pubmed	Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.	ESR1 ESR2	5.49e-06	2	82	2	19382890
Pubmed	Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.	ESR1 ESR2	5.49e-06	2	82	2	20850223
Pubmed	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	ESR1 ESR2	5.49e-06	2	82	2	24859835
Pubmed	Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.	ESR1 ESR2	5.49e-06	2	82	2	24192230
Pubmed	Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.	ESR1 ESR2	5.49e-06	2	82	2	11557741
Pubmed	Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.	ESR1 ESR2	5.49e-06	2	82	2	12952206
Pubmed	Determination of the isoflavone composition and estrogenic activity of commercial dietary supplements based on soy or red clover.	ESR1 ESR2	5.49e-06	2	82	2	26023053
Pubmed	Both estrogen receptor-alpha and -beta are required for sexual differentiation of the anteroventral periventricular area in mice.	ESR1 ESR2	5.49e-06	2	82	2	16239299
Pubmed	Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis.	ESR1 ESR2	5.49e-06	2	82	2	17522255
Pubmed	Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.	ESR1 ESR2	5.49e-06	2	82	2	28823012
Pubmed	Estrogen receptor polymorphisms and the vascular effects of hormone therapy.	ESR1 ESR2	5.49e-06	2	82	2	21106950
Pubmed	Untangling the human estrogen receptor gene structure.	ESR1 ESR2	5.49e-06	2	82	2	12111450
Pubmed	Generation and reproductive phenotypes of mice lacking estrogen receptor beta.	ESR1 ESR2	5.49e-06	2	82	2	9861029
Pubmed	Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status.	ESR1 ESR2	5.49e-06	2	82	2	12691862
Pubmed	Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas.	DEFA1 DEFA3	5.49e-06	2	82	2	18957723
Pubmed	Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.	ESR1 ESR2	5.49e-06	2	82	2	24833090
Pubmed	Long-Term Neonatal Estrogen Exposure Causes Irreversible Inhibition of LH Pulses by Suppressing Arcuate Kisspeptin Expression via Estrogen Receptors α and β in Female Rodents.	ESR1 ESR2	5.49e-06	2	82	2	28368450
Pubmed	Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury.	ESR1 ESR2	5.49e-06	2	82	2	15698835
Pubmed	The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent.	ESR1 ESR2	5.49e-06	2	82	2	23499841
Pubmed	The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.	ESR1 ESR2	5.49e-06	2	82	2	22615145
Pubmed	Novel effects of estradiol and estrogen receptor alpha and beta on cognitive function.	ESR1 ESR2	5.49e-06	2	82	2	11074057
Pubmed	Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.	ESR1 ESR2	5.49e-06	2	82	2	21586296
Pubmed	Effects of low-magnitude high-frequency vibration on osteoblasts are dependent on estrogen receptor α signaling and cytoskeletal remodeling.	ESR1 ESR2	5.49e-06	2	82	2	30093109
Pubmed	Estrogen receptors in breast carcinogenesis and endocrine therapy.	ESR1 ESR2	5.49e-06	2	82	2	25433206
Pubmed	Estrogen receptor null mice: what have we learned and where will they lead us?	ESR1 ESR2	5.49e-06	2	82	2	10368776
Pubmed	Association of estrogen receptor gene polymorphisms with susceptibility to adolescent idiopathic scoliosis.	ESR1 ESR2	5.49e-06	2	82	2	16648749
Pubmed	Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.	ESR1 ESR2	5.49e-06	2	82	2	12727987
Pubmed	Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens.	ESR1 ESR2	5.49e-06	2	82	2	14761887
Pubmed	Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.	ESR1 ESR2	5.49e-06	2	82	2	18752050
Pubmed	Estrogen receptors alpha and beta in choroid plexus epithelial cells in Alzheimer's disease.	ESR1 ESR2	5.49e-06	2	82	2	15082146
Pubmed	Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.	ESR1 ESR2	5.49e-06	2	82	2	17634528
Pubmed	Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice.	ESR1 ESR2	5.49e-06	2	82	2	20308571
Pubmed	Association of polymorphisms in the estrogen receptors alpha, and beta (ESR1, ESR2) with the occurrence of male infertility and semen parameters.	ESR1 ESR2	5.49e-06	2	82	2	20599614
Pubmed	Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta.	ESR1 ESR2	5.49e-06	2	82	2	15167447
Pubmed	Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.	ESR1 ESR2	5.49e-06	2	82	2	12242035
Pubmed	Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation.	ESR1 ESR2	5.49e-06	2	82	2	17548071
Pubmed	[Prognostic value of estrogen receptors--ERalpha and ERbeta, in patients with lung cancer].	ESR1 ESR2	5.49e-06	2	82	2	21972702
Pubmed	The role of allelic variation in estrogen receptor genes and major depression in the Nurses Health Study.	ESR1 ESR2	5.49e-06	2	82	2	26169989
Pubmed	A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation.	ESR1 ESR2	5.49e-06	2	82	2	23702470
Pubmed	Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.	ESR1 ESR2	5.49e-06	2	82	2	32632016
Pubmed	Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.	ESR1 ESR2	5.49e-06	2	82	2	16648639
Pubmed	Association between polymorphisms in genes encoding estrogen receptors (ESR1 and ESR2) and excreted bisphenol A levels after orthodontic bracket bonding: a preliminary study.	ESR1 ESR2	5.49e-06	2	82	2	29961922
Pubmed	Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology.	TRAF6 SMO	5.49e-06	2	82	2	30165192
Pubmed	Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.	ESR1 ESR2	5.49e-06	2	82	2	26251204
Pubmed	Bisphenol A exposure in utero disrupts early oogenesis in the mouse.	ESR1 ESR2	5.49e-06	2	82	2	17222059
Pubmed	Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue.	ESR1 ESR2	5.49e-06	2	82	2	11703424
Pubmed	Estrogen receptor beta gene variant is associated with vascular dementia in elderly women.	ESR1 ESR2	5.49e-06	2	82	2	19473078
Pubmed	3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.	ESR1 ESR2	5.49e-06	2	82	2	22921477
Cytoband	Ensembl 112 genes in cytogenetic band chr4q32	TRIM75 FSTL5 MARCHF1	1.33e-03	120	82	3	chr4q32
Cytoband	4q32.3	TRIM75 FSTL5	1.70e-03	34	82	2	4q32.3
Cytoband	1p33	CYP4Z1 CYP4X1	1.80e-03	35	82	2	1p33
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	4.65e-08	3	66	3	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3 CELSR2	4.65e-08	3	66	3	1189
GeneFamily	Ring finger proteins	CBLL1 TRAF6 TRIM75 MARCHF8 MARCHF2 SCAF11 TRIM77 TRIM27 MARCHF1	6.63e-07	275	66	9	58
GeneFamily	Ring finger proteins\|Membrane associated ring-CH-type fingers	MARCHF8 MARCHF2 MARCHF1	7.51e-06	11	66	3	60
GeneFamily	Anoctamins	ANO4 ANO3	5.80e-04	10	66	2	865
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD10 SMO	7.07e-04	11	66	2	286
GeneFamily	Defensins, alpha	DEFA1 DEFA3	8.46e-04	12	66	2	502
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM75 TRIM77 TRIM27	5.06e-03	95	66	3	59
GeneFamily	Cytochrome P450 family 4	CYP4Z1 CYP4X1	7.63e-03	36	66	2	1003
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	LPAR4 SLIT3 MMP23B SMO BMPER PRG4	1.84e-06	199	82	6	60a653100aff31f7f96796ff2ec634798bfb4b0d
ToppCell	Kidney-Keratinocytes\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	IL34 ADORA2B CNFN SCEL RFX8 USP9Y	1.89e-06	200	82	6	41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	USP44 CELSR1 GPC5 MARVELD3 SCEL	8.01e-06	148	82	5	9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMP23B FZD10 BMPER RFX8 NKRF	1.28e-05	163	82	5	b83a35c4426d66b5734a98fa6c72b345fe462030
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMP23B FZD10 BMPER RFX8 NKRF	1.28e-05	163	82	5	c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91
ToppCell	facs-Marrow-KLS-24m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMP23B FZD10 BMPER RFX8 NKRF	1.32e-05	164	82	5	d2b5f51af7fcffddebe997ee302bacbd85d76852
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP4Z1 ESR1 CYP4X1 ANO3 KCNT1	1.48e-05	168	82	5	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ADORA2B SLIT3 MARCHF1 WDPCP	1.52e-05	169	82	5	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANO4 TRAF6 ASIC1 FSTL5 MARCHF1	1.57e-05	170	82	5	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	ASK440-Epithelial-Transformed_epithelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CELSR2 CYP4Z1 SLIT3 PRG4 ANO3	1.66e-05	172	82	5	df3800bcd9777d02900eba0cfc26ab73de8a1d95
ToppCell	356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CYP4X1 TRPV6 SMO MUC5AC FAM221B	1.80e-05	175	82	5	af9c5104c86231cfdb93a0f7d7032379efaa009e
ToppCell	356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CYP4X1 TRPV6 SMO MUC5AC FAM221B	1.80e-05	175	82	5	4bfae78ac3a2cb9404382aae96d291504a9cfa14
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CELSR1 CYP4Z1 CYP4X1 GPC5 SCEL	2.29e-05	184	82	5	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B TIMP2 SLIT3 MMP23B PRG4	2.41e-05	186	82	5	ff6ccfdf2509f96caa10281c29a95b432f6c6dcc
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	CELSR1 CYP4Z1 CYP4X1 GPC5 SCEL	2.41e-05	186	82	5	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CELSR1 CYP4Z1 CYP4X1 GPC5 SCEL	2.54e-05	188	82	5	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CELSR1 FSTL5 GPC5 MARVELD3 MUC5AC	2.74e-05	191	82	5	05731ece7867659c662f952812805f947032fe10
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B ASIC1 FSTL5 GPC5 SCEL	2.74e-05	191	82	5	ece87127f85939e61b1048d968ed96f0e87c3a79
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B ASIC1 FSTL5 GPC5 SCEL	2.74e-05	191	82	5	478e8341ee03b05501e2233e02cef5f97492c95d
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	USP44 MARCHF8 INTS9 USP9Y DICER1	2.74e-05	191	82	5	cadb7a9de16f4bb21606de0e25cddd2d748c7f0b
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMP2 SLIT3 MMP23B BMPER PRG4	2.81e-05	192	82	5	853a930e0641ffb50cbb4cef5837c70d75c3fc39
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMP2 SLIT3 MMP23B BMPER PRG4	2.81e-05	192	82	5	d2c03490c5e835d0f0a732803093c64b8d4b4029
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMP2 SLIT3 MMP23B BMPER PRG4	2.81e-05	192	82	5	49281626ecad0456fdbded2378b7028d7b589686
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CELSR1 FSTL5 GPC5 MARVELD3 MUC5AC	2.88e-05	193	82	5	aa10924b203c71e65fdbd2b90ba131dbd362d8b1
ToppCell	VE-mDC1-\|VE / Condition, Cell_class and T cell subcluster	ZNF462 ADORA2B CNFN SMO MARCHF1	2.88e-05	193	82	5	5df6033bc0e4f96a20d526486a8e89c990e21831
ToppCell	VE-mDC1\|VE / Condition, Cell_class and T cell subcluster	ZNF462 ADORA2B CNFN SMO MARCHF1	2.88e-05	193	82	5	12b2708db9db8b88365b8ebeb4908f28c50081bb
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CELSR1 FSTL5 GPC5 MARVELD3 MUC5AC	2.88e-05	193	82	5	de569c6e507856fd3ac2311f246cb597074ed30c
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CELSR1 SINHCAF FSTL5 GPC5 MARVELD3	3.18e-05	197	82	5	4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ESR1 SLIT3 MMP23B RFX8 PRG4	3.25e-05	198	82	5	0cd930e374c2c48d1991b51c025f9801b22ecee7
ToppCell	Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ESR1 SLIT3 MMP23B RFX8 PRG4	3.25e-05	198	82	5	e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30
ToppCell	COVID_non-vent-Myeloid-Monocytic-Developing_Neutrophil\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DEFA1 DEFA3 OR2W3 CNFN	1.01e-04	131	82	4	5b29f0dc449b9fff5e8bf6365080168f31b7e268
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231\|Adult / Lineage, Cell type, age group and donor	IL34 CELSR3 GPC5 SCEL	1.04e-04	132	82	4	8d30b71776f5f6da55dc78e0c5cb27be460004e3
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DEFA3 TRAF6 FSTL5 BMPER	1.16e-04	136	82	4	9cf076597e6fd9390850fda259daa13022f15893
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ASIC1 TTC16 ESR1 BMPER	1.23e-04	138	82	4	05de2cef97c0912fb23f138dd45348f565a14d74
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANO4 ASIC1 FSTL5 MARVELD3	1.65e-04	149	82	4	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CELSR3 SACS SLC25A29 MARCHF1	1.70e-04	150	82	4	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CELSR3 SACS SLC25A29 MARCHF1	1.70e-04	150	82	4	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Club\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	SPACA4 ESR2 CYP4X1 MUC5AC	2.07e-04	158	82	4	03281e87780e3bacd089903383c016d03c373bf7
ToppCell	PND07-Endothelial-Endothelial_lymphatic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CELSR1 STAB2 DOCK9 FNDC8	2.22e-04	161	82	4	133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CELSR1 STAB2 DOCK9 FNDC8	2.22e-04	161	82	4	9466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CELSR1 STAB2 DOCK9 FNDC8	2.22e-04	161	82	4	cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 ESR1 SLIT3 ANO3	2.28e-04	162	82	4	68c40d12689cc1b6c797e6e48173f0110f8144e4
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CELSR1 STAB2 DOCK9 FNDC8	2.28e-04	162	82	4	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 ESR1 SLIT3 ANO3	2.28e-04	162	82	4	735fa3f77b31a4189e431d05c326403c18cbbffb
ToppCell	NS-control-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ESR2 DEF6 MMP23B FAM221B	2.44e-04	165	82	4	8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	THAP3 SCEL ZNF598 PRG4	2.44e-04	165	82	4	9d2bdc42c13c8c2a68889bec8612a1ce56f659fa
ToppCell	control-Myeloid-pDC\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ESR2 DEF6 MMP23B FAM221B	2.44e-04	165	82	4	243c74adf8d993ff92acbff2768bdc5a1693eca3
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLIT3 MUC5AC KCNT1 MOCS1	2.44e-04	165	82	4	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B TRPV6 IL18RAP MOCS1	2.50e-04	166	82	4	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B TRPV6 IL18RAP MOCS1	2.50e-04	166	82	4	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	SMO BMPER ANO3 SEMA4C	2.56e-04	167	82	4	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMS22L ESR1 DEF6 IL18RAP	2.61e-04	168	82	4	93b7138f17aa14a6398c9b4ea7237781a0e19a66
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 ESR1 SLIT3 PRG4	2.61e-04	168	82	4	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMS22L ESR1 DEF6 IL18RAP	2.61e-04	168	82	4	e393553208617a023f1646169c892a87c95db3f5
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMP2 RFX8 MUC5AC SEMA4C	2.67e-04	169	82	4	7962165cab84af73d20b56eb70b1ed87c94025ef
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP4Z1 ESR1 CYP4X1 KCNT1	2.80e-04	171	82	4	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ZPLD1 ESR2 FNDC8	2.80e-04	69	82	3	9778ec48eceef5bd6f59b5b55ca4a6cc348a1eba
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ZPLD1 ESR2 FNDC8	2.80e-04	69	82	3	8c4c4e2cd4c319adbe44fa2bcb5bb5cd5d81a2fd
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	TRPV6 SLC25A29 SCEL MUC5AC	2.86e-04	172	82	4	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	SLIT3 CCNP BMPER MOCS1	2.92e-04	173	82	4	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 DEF6 IL18RAP PRG4	2.99e-04	174	82	4	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IL34 CELSR2 CCNP SLC25A29	2.99e-04	174	82	4	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 DEF6 IL18RAP PRG4	2.99e-04	174	82	4	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SINHCAF MMP23B SLC25A29 BMPER	3.05e-04	175	82	4	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ADORA2B MARCHF8 IL18RAP	3.05e-04	175	82	4	1b35acece23712ab7e3f92d9d68266efd38b3ef5
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADORA2B MMS22L SACS SLC25A29	3.05e-04	175	82	4	a5db428b078938627e61b7e944c1e0c1d61ac2da
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADORA2B MMS22L SACS SLC25A29	3.05e-04	175	82	4	8b498eea1ec1c1f27b171025c3d08adf3687bafc
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 ADORA2B MARCHF8 IL18RAP	3.05e-04	175	82	4	a9f88054e2c28d604c65ed785f63021aadb7f4c8
ToppCell	facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 STAB2 FNDC8 KCNT1	3.12e-04	176	82	4	057d2759fdc67176c25802b57a78064d8cc93205
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 STAB2 FNDC8 KCNT1	3.12e-04	176	82	4	b81e5d23b31cefc8d374ef403e21acc390c14a80
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CELSR1 ESR2 SLIT3 MARCHF1	3.19e-04	177	82	4	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	LPAR4 BMPER RFX8 ANO3	3.26e-04	178	82	4	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLIT3 MMP23B SCEL KCNT1	3.26e-04	178	82	4	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLIT3 MMP23B SCEL KCNT1	3.26e-04	178	82	4	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	ASK440-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	CYP4Z1 SLIT3 PRG4 ANO3	3.26e-04	178	82	4	86f1741636ed3e85bb4a65f84949b718fc38c290
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SACS SLIT3 RFX8 IL18RAP	3.33e-04	179	82	4	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP44 CELSR2 GPC5 SCEL	3.33e-04	179	82	4	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CELSR1 PLA2G12B UMOD GPC5	3.33e-04	179	82	4	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FZD10 SMO BMPER MOCS1	3.33e-04	179	82	4	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 STAB2 FZD10 PRG4	3.40e-04	180	82	4	b28363626f4d2a552abde3434cc1df2e2121aba5
ToppCell	droplet-Limb_Muscle-nan-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIMP2 SLIT3 BMPER PRG4	3.40e-04	180	82	4	d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 STAB2 FZD10 PRG4	3.40e-04	180	82	4	67b062f2ef7e20f392e00c646f4985c415d40de9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELSR1 SLIT3 MARCHF1 ANO3	3.40e-04	180	82	4	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RFX8 USP9Y IL18RAP	3.45e-04	74	82	3	ef4c9eafc794c7d50aef28b37d21b52d3c511499
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RFX8 USP9Y IL18RAP	3.45e-04	74	82	3	6ecbdf4186039a031410e09ecd5afa66b6d5e2dc
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B MMS22L TIMP2 MMP23B	3.47e-04	181	82	4	c7f5aedcb74c21fb587a95a16d700e2a38a380ee
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2B MMS22L TIMP2 MMP23B	3.47e-04	181	82	4	0ec9621a078d004bbd25a587757d24b5cf162959
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CELSR1 STAB2 FNDC8 KCNT1	3.54e-04	182	82	4	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 TIMP2 ASIC1 FSTL5	3.54e-04	182	82	4	420a8fd30543e37a66ba0786215d056d308660d0
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CELSR1 STAB2 FNDC8 KCNT1	3.54e-04	182	82	4	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF142 NFX1 MUC5AC MOCS1	3.54e-04	182	82	4	818b5155ec81f0059048d6070a108116ecd72e3c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELSR1 FSTL5 SLIT3 ANO3	3.54e-04	182	82	4	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CELSR1 STAB2 FNDC8 KCNT1	3.54e-04	182	82	4	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CELSR1 FSTL5 SLIT3 ANO3	3.54e-04	182	82	4	05c167158815bf25d509df59ab386e1990712765
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CELSR1 FSTL5 GPC5 MARVELD3	3.62e-04	183	82	4	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Late_airway_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CELSR2 TRPV6 GPC5 MARVELD3	3.62e-04	183	82	4	0cea883a8a79fc58abcb26b08bf5db9d3d60f7d4
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	UMOD BMPER RFX8 MOCS1	3.62e-04	183	82	4	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 ESR1 SLIT3 ANO3	3.69e-04	184	82	4	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 ESR1 SLIT3 ANO3	3.69e-04	184	82	4	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	CYP4Z1 CYP4X1 GPC5 SCEL	3.69e-04	184	82	4	561592edc3083fad41b91811151b442207c65dd9
Drug	4-fluorobenzoyl chloride	DEFA1 DEFA3 ESR1	1.80e-07	4	82	3	CID000067879
Drug	P 14	DEFA1 DEFA3 ESR2	1.25e-05	13	82	3	CID000056603
Drug	5-octylphenol	ESR1 ESR2	1.28e-05	2	82	2	ctd:C113977
Drug	2-methoxyethoxy)acetic acid	DEFA1 DEFA3	1.28e-05	2	82	2	CID000027642
Drug	tetradifon	ESR1 ESR2	1.28e-05	2	82	2	ctd:C005807
Drug	etocrylene	ESR1 ESR2	1.28e-05	2	82	2	CID000243274
Drug	Raloxifene	ESR1 ESR2	1.28e-05	2	82	2	DB00481
Drug	Brn 0187733	ESR1 ESR2	1.28e-05	2	82	2	CID000160446
Drug	PHTPP	ESR1 ESR2	1.28e-05	2	82	2	CID011201035
Drug	butolame	ESR1 ESR2	1.28e-05	2	82	2	CID000197608
Drug	LY 326315	ESR1 ESR2	1.28e-05	2	82	2	CID009803972
Drug	JK 1624F2-1	ESR1 ESR2	1.28e-05	2	82	2	ctd:C113642
Drug	octocrylene	ESR1 ESR2	1.28e-05	2	82	2	ctd:C088673
Drug	O-desmethylangolensin	ESR1 ESR2	1.28e-05	2	82	2	ctd:C050052
Drug	CHEMBL397775	ESR1 ESR2	1.28e-05	2	82	2	CID010214678
Drug	Cyclohexanone, 3b	ESR1 ESR2	1.28e-05	2	82	2	CID011370317
Drug	CHEMBL234633	ESR1 ESR2	1.28e-05	2	82	2	CID010192968
Drug	SureCN14514707	ESR1 ESR2	1.28e-05	2	82	2	CID010192967
Drug	(4R)-6-(ethoxymethyl)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.28e-05	2	82	2	CID011175195
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.28e-05	2	82	2	DB08020
Drug	ethyl cinnamate	ESR1 ESR2	1.28e-05	2	82	2	ctd:C451418
Drug	(4R)-4-(4-hydroxyphenyl)-6-methylol-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.28e-05	2	82	2	CID011174414
Drug	1,2,5,6-tetramethylnaphthalene	DEFA1 DEFA3	1.28e-05	2	82	2	CID006427081
Drug	phytoene	ESR1 ESR2	1.28e-05	2	82	2	ctd:C100185
Drug	CHEMBL48352	ESR1 ESR2	1.28e-05	2	82	2	CID011522286
Drug	bromophos	ESR1 ESR2	1.28e-05	2	82	2	ctd:C100092
Drug	SureCN14514705	ESR1 ESR2	1.28e-05	2	82	2	CID010125414
Drug	3,4-dihydroxybenzaldoxime	ESR1 ESR2	1.28e-05	2	82	2	ctd:C053286
Drug	Tamoxifen	ESR1 ESR2	1.28e-05	2	82	2	DB00675
Drug	SureCN14514737	ESR1 ESR2	1.28e-05	2	82	2	CID010149292
Drug	di-(5-methylhexyl)phthalate	ESR1 ESR2	1.28e-05	2	82	2	ctd:C042791
Drug	1,4,5-trimethylnaphthalene	DEFA1 DEFA3	1.28e-05	2	82	2	CID000016478
Drug	phytofluene	ESR1 ESR2	1.28e-05	2	82	2	ctd:C003140
Drug	1x7e	ESR1 ESR2	1.28e-05	2	82	2	CID000656953
Drug	salicylaldoxime	ESR1 ESR2	1.28e-05	2	82	2	ctd:C005704
Drug	Pyrazolo[1,5-a]pyrimidine, 12d	ESR1 ESR2	1.28e-05	2	82	2	CID016103245
Drug	Pyrazolo[1,5-a]pyrimidine, 12c	ESR1 ESR2	1.28e-05	2	82	2	CID016103238
Drug	SureCN3587271	ESR1 ESR2	1.28e-05	2	82	2	CID011208678
Drug	CNP-amino	ESR1 ESR2	1.28e-05	2	82	2	CID000033473
Drug	ERB 041	ESR1 ESR2	1.28e-05	2	82	2	ctd:C478102
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.28e-05	2	82	2	DB07933
Drug	4-(4-hydroxyphenyl)-6-methyl-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.28e-05	2	82	2	CID010125512
Drug	2-phenylbenzofuran	ESR1 ESR2	1.28e-05	2	82	2	CID003517936
Drug	steroid C	ESR1 ESR2	1.28e-05	2	82	2	CID000454473
Drug	p-sulfobenzyl alcohol	DEFA1 DEFA3	1.28e-05	2	82	2	CID000441138
Drug	2z4b	ESR1 ESR2	1.28e-05	2	82	2	CID011197931
Drug	dehydroestrone	ESR1 ESR2	1.28e-05	2	82	2	CID000102225
Drug	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.28e-05	2	82	2	DB07638
Drug	prolame	ESR1 ESR2	1.28e-05	2	82	2	CID000127441
Drug	benzohydrol	ESR1 ESR2	1.28e-05	2	82	2	ctd:C020225
Drug	parthenocissin A	ESR1 ESR2	1.28e-05	2	82	2	ctd:C549189
Drug	CHEBI:428946	ESR1 ESR2	1.28e-05	2	82	2	CID011688293
Drug	F ppt	ESR1 ESR2	1.28e-05	2	82	2	CID003035869
Drug	SureCN3118249	ESR1 ESR2	1.28e-05	2	82	2	CID011519653
Drug	SureCN4017709	ESR1 ESR2	1.28e-05	2	82	2	CID011256602
Drug	CHEBI:428959	ESR1 ESR2	1.28e-05	2	82	2	CID011638242
Drug	DNC005795	ESR1 ESR2	1.28e-05	2	82	2	CID011638264
Drug	tetrahydrodaidzein	ESR1 ESR2	1.28e-05	2	82	2	ctd:C433164
Drug	tri-(2-ethylhexyl)trimellitate	ESR1 ESR2	1.28e-05	2	82	2	ctd:C036101
Drug	2-chloro-4-phenylphenol	ESR1 ESR2	1.28e-05	2	82	2	ctd:C012257
Drug	2,2,4-trimethyl-1,3-pentanediol diisobutyrate	ESR1 ESR2	1.28e-05	2	82	2	ctd:C001508
Drug	2-(3-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propane	ESR1 ESR2	1.28e-05	2	82	2	ctd:C497826
Drug	2,2-bis(3-chloro-4-hydroxyphenyl)propane	ESR1 ESR2	1.28e-05	2	82	2	ctd:C497827
Drug	1-ethyl-2-(4-hydroxyphenyl)-3H-inden-5-ol	ESR1 ESR2	1.28e-05	2	82	2	CID011615788
Drug	SureCN3593776	ESR1 ESR2	1.28e-05	2	82	2	CID009948127
Drug	SureCN14047367	ESR1 ESR2	1.28e-05	2	82	2	CID010171723
Drug	Y134 compound	ESR1 ESR2	1.28e-05	2	82	2	ctd:C518540
Drug	TS 108	ESR1 ESR2	1.28e-05	2	82	2	ctd:C482068
Drug	Estriol	ESR1 ESR2	1.28e-05	2	82	2	DB04573
Drug	Estropipate	ESR1 ESR2	1.28e-05	2	82	2	DB04574
Drug	CHEBI:428952	ESR1 ESR2	1.28e-05	2	82	2	CID011674420
Drug	6-(4-hydroxyphenyl)-6,6a,7,8,9,10,11,11a-octahydrocyclohepta[c]chromen-2-ol	ESR1 ESR2	1.28e-05	2	82	2	CID010215026
Drug	4-(2-chloro-4-(2-piperidin-1-ylethoxy)phenyl)-5-(2,6-dichloro-4-hydroxyphenyl)-2-imidazoline	ESR1 ESR2	1.28e-05	2	82	2	ctd:C496952
Drug	indenestrol	ESR1 ESR2	1.28e-05	2	82	2	ctd:C047437
Drug	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	ESR1 ESR2	1.28e-05	2	82	2	DB06927
Drug	LY2066948	ESR1 ESR2	1.28e-05	2	82	2	CID005327043
Drug	SERBA-2	ESR1 ESR2	1.28e-05	2	82	2	CID009925763
Drug	SureCN1360427	ESR1 ESR2	1.28e-05	2	82	2	CID011720174
Drug	16 alpha-iodoestradiol	ESR1 ESR2	1.28e-05	2	82	2	ctd:C024871
Drug	2-(((3,5-dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid	ESR1 ESR2	3.84e-05	3	82	2	ctd:C101851
Drug	CHF 4056	ESR1 ESR2	3.84e-05	3	82	2	ctd:C450419
Drug	Diethylstilbestrol	ESR1 ESR2	3.84e-05	3	82	2	DB00255
Drug	AC1LGHHD	ESR1 ESR2	3.84e-05	3	82	2	CID000821427
Drug	cyanophenphos	ESR1 ESR2	3.84e-05	3	82	2	ctd:C002488
Drug	4-ethylbenzoate	DEFA1 DEFA3	3.84e-05	3	82	2	CID000012086
Drug	2,4,6-trichlorophenyl-4'-aminophenyl ether	ESR1 ESR2	3.84e-05	3	82	2	ctd:C067259
Drug	7alpha-methyl-17alpha-ethynylestradiol	ESR1 ESR2	3.84e-05	3	82	2	ctd:C475050
Drug	bromophos-ethyl	ESR1 ESR2	3.84e-05	3	82	2	CID000020965
Drug	dihydrobiochanin A	ESR1 ESR2	3.84e-05	3	82	2	CID000439784
Drug	Estradiol	ESR1 ESR2	3.84e-05	3	82	2	DB00783
Drug	bicyclo(3.3.1)nonane	ESR1 ESR2	3.84e-05	3	82	2	CID000136101
Drug	cedrol	ESR1 ESR2	3.84e-05	3	82	2	ctd:C078669
Drug	benzophenone-6	ESR1 ESR2	3.84e-05	3	82	2	CID000008570
Drug	dichlofenthion	ESR1 ESR2	3.84e-05	3	82	2	CID000007328
Drug	Nafoxidine	ESR1 ESR2	3.84e-05	3	82	2	ctd:D009256
Drug	LY2066948	ESR1 ESR2	3.84e-05	3	82	2	ctd:C504960
Drug	p-tert-amylphenol	ESR1 ESR2	3.84e-05	3	82	2	ctd:C019566
Drug	1-(4-nitro-2-(trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)piperazine	ESR1 ESR2	3.84e-05	3	82	2	ctd:C562246
Drug	Chromans	ESR1 ESR2	3.84e-05	3	82	2	ctd:D002839
Drug	4-hydroxybenzophenone	ESR1 ESR2	3.84e-05	3	82	2	ctd:C024292
Disease	prostate carcinoma in situ (implicated_via_orthology)	ESR1 ESR2	6.55e-06	2	76	2	DOID:8634 (implicated_via_orthology)
Disease	peritonitis (implicated_via_orthology)	ESR1 ESR2	1.96e-05	3	76	2	DOID:8283 (implicated_via_orthology)
Disease	Subfertility, Female	ESR1 ESR2 SMO	5.14e-05	28	76	3	C0341869
Disease	Sterility, Postpartum	ESR1 ESR2 SMO	5.14e-05	28	76	3	C0038279
Disease	Female sterility	ESR1 ESR2 SMO	5.14e-05	28	76	3	C0917730
Disease	Female infertility	ESR1 ESR2 SMO	5.14e-05	28	76	3	C0021361
Disease	anxiety measurement	MMS22L ESR1 TRPV6 WDPCP	1.78e-04	108	76	4	EFO_0009863
Disease	repulsive guidance molecule A measurement	CELSR2 FAM221B	2.33e-04	9	76	2	EFO_0008273
Disease	interleukin 12 measurement	ZNF462 SACS NFX1	3.51e-04	53	76	3	EFO_0004753
Disease	Prostatic Intraepithelial Neoplasias	ESR1 ESR2	3.55e-04	11	76	2	C0282612
Disease	Oligospermia	ESR1 DICER1	4.25e-04	12	76	2	C0028960
Disease	sexual dimorphism measurement	ZNF462 ZNF142 ASIC1 ESR1 ESR2 MARCHF2 SLIT3 DEF6 TRIM27 SDHB	5.32e-04	1106	76	10	EFO_0021796
Disease	Coronary Arteriosclerosis	TRAF6 ESR1 ESR2	6.39e-04	65	76	3	C0010054
Disease	Coronary Artery Disease	TRAF6 ESR1 ESR2	6.39e-04	65	76	3	C1956346
Disease	Corneal astigmatism	DOCK9 BMPER NPLOC4	1.05e-03	77	76	3	EFO_1002040
Disease	skin hydration measurement	IL34 FZD10	1.33e-03	21	76	2	EFO_0009586
Disease	in situ carcinoma (is_marker_for)	ESR1 ESR2	1.33e-03	21	76	2	DOID:8719 (is_marker_for)
Disease	osteoporosis (biomarker_via_orthology)	ESR1 ESR2	1.46e-03	22	76	2	DOID:11476 (biomarker_via_orthology)
Disease	childhood aggressive behaviour measurement	ZPLD1 RFX8 TRIM27	1.59e-03	89	76	3	EFO_0007663
Disease	sphingomyelin 24:1 measurement	MMS22L CELSR1	1.60e-03	23	76	2	EFO_0010398
Disease	Cerebral Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0750935
Disease	Intracranial Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0750936
Disease	Pilocytic Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0334583
Disease	Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0004114
Disease	Juvenile Pilocytic Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0280783
Disease	Diffuse Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0280785
Disease	Grade I Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0205768
Disease	Mixed oligoastrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0547065
Disease	Childhood Cerebral Astrocytoma	ESR1 ESR2	1.89e-03	25	76	2	C0338070
Disease	Gemistocytic astrocytoma	ESR1 ESR2	2.04e-03	26	76	2	C0334581
Disease	Protoplasmic astrocytoma	ESR1 ESR2	2.04e-03	26	76	2	C0334580
Disease	Fibrillary Astrocytoma	ESR1 ESR2	2.04e-03	26	76	2	C0334582
Disease	Anaplastic astrocytoma	ESR1 ESR2	2.20e-03	27	76	2	C0334579
Disease	osteoarthritis (is_implicated_in)	ESR1 ESR2	2.37e-03	28	76	2	DOID:8398 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
CCLVKCLFENVVPMS	ADORA2B	166	P29275
ICLREPCENYMKCVS	CELSR1	1306	Q9NYQ6
ICLREPCENYMRCVS	CELSR2	1231	Q9HCU4
ATDIIMCPVCDKYCP	ANO4	391	Q32M45
ACLFVACKMEECVLP	CCNP	156	Q9H8S5
YREIMKLCENCPSCP	DICER1	186	Q9UPY3
QEICKATEVFMCPLC	ANO3	431	Q9BYT9
MKCIYCPIDTRLNFI	INTS9	441	Q9NV88
ETCIICCYEQRTMGK	VCPKMT	166	Q9H867
CRPKMIKSPYDVACC	IL18RAP	126	O95256
CQACRLRKCYEVGMV	ESR2	201	Q92731
PRTEKRTLCCDMVCF	MARCHF2	131	Q9P0N8
PTCCTRKMEERYQIA	GPC5	66	P78333
KSLPLYLQGMCIVCC	MMS22L	996	Q6ZRQ5
IMYPITLCLATLNCC	LPAR4	291	Q99677
EECKYAMLALNCICP	KCNT1	491	Q5JUK3
SCQACRLRKCYEVGM	ESR1	236	P03372
AVMAYDRCVAICKPL	OR2W3	116	Q7Z3T1
ISVPCKVSQCRCFMF	FAM221B	286	A6H8Z2
CMALVRDECLLPCKD	NPLOC4	391	Q8TAT6
CRDMYECSCPELDQL	GALK2	371	Q01415
LTTEKYECMVCCELV	NFX1	351	Q12986
YECMVCCELVRVTAP	NFX1	356	Q12986
RCCELCKYEFIMETK	MARCHF8	121	Q5T0T0
FKMCLNYEVRVLCCE	MUC5AC	2201	P98088
PFKMCLNYEVRVLCC	MUC5AC	3306	P98088
KMCLNYEVRVLCCET	MUC5AC	3606	P98088
PFKMCLNYEVRVLCC	MUC5AC	4711	P98088
PAMTKCCNQLDVCYD	PLA2G12B	106	Q9BX93
RCCELCKYDFIMETK	MARCHF1	121	Q8TCQ1
LTEKCNLRCQYCMPE	MOCS1	76	Q9NZB8
ECACMDLCKRHYKPV	FSTL5	86	Q8N475
RMIPCKHVFCYDCAI	CBLL1	121	Q75N03
CRVMCEQARLKCSPI	FZD10	106	Q9ULW2
EPMADSCIYECIRNK	WDPCP	311	O95876
PIYCICRKPDINCFM	CXXC1	26	Q9P0U4
VMELLYCSCCKQSSV	IL34	171	Q6ZMJ4
FITDNPCIMCVCLNK	BMPER	61	Q8N8U9
YRSCVTDMCECPVHK	BMPER	581	Q8N8U9
RKNMACYCRIPACIA	DEFA1	61	P59665
RADMCAALCYEILKC	DOCK9	1471	Q9BZ29
RKNMDCYCRIPACIA	DEFA3	61	P59666
YTTMCIKETCRLIPA	CYP4X1	366	Q8N118
RCSVCKMVIYCDQTC	ANKMY2	331	Q8IV38
CCVEVLPDRDGKRCM	DEF6	266	Q9H4E7
QCVICCPMELAKTRL	SLC25A29	106	Q8N8R3
CKYLCTGRACCQMLE	MARVELD3	191	Q96A59
ERKSPYVAVCCIVMA	TMEM167A	51	Q8TBQ9
DNVCLREPCENYMKC	CELSR3	1376	Q9NYQ7
REPCENYMKCVSVLR	CELSR3	1381	Q9NYQ7
PESCNHVFCMTCILK	SCAF11	56	Q99590
KDCVFCELTDSMQCP	SPACA4	21	Q8TDM5
IMKPIHECCYCDIKV	SACS	1391	Q9NZJ4
MGCRCCKIIQSYLFD	C4orf19	1	Q8IY42
QLCYSCRVNMKDLPS	CTU2	461	Q2VPK5
CMICLAAEYPAVKFC	PDCL	201	Q13371
MELKPNTCYCLSVRA	FNDC8	246	Q8TC99
YCEEDQMPICVVCDR	TRIM27	106	P14373
YMLTRCIQACKTNPE	NKRF	201	O15226
RLMKRLCPSSCDFCY	MMP23B	276	O75900
PVADCMKYRSCADCV	SEMA4C	496	Q9C0C4
MKYRSCADCVLARDP	SEMA4C	501	Q9C0C4
QHYMECCPDFKRVCT	PRG4	51	Q92954
SAACIQCLDCRLMYP	SKI	241	P12755
KDQEYCVCEMPCNLT	ASIC1	356	P78348
CVCEMPCNLTRYGKE	ASIC1	361	P78348
CLPCALCQMARELKI	CNFN	96	Q9BYD5
TMCIKECLRLYAPVV	CYP4Z1	366	Q86W10
KPKMYRSIEGCCICR	SINHCAF	6	Q9NP50
SSECFMDLVCPEKCR	SLIT3	496	O75094
CCPVCREISQQMYFK	TRIM77	51	I1YAP6
CVTKLCRADDCPFLM	ZPLD1	296	Q8TCW7
CEVYLCDTMNEKCKP	UMOD	566	P07911
CICEECSVPRCLMYE	RFX8	31	Q6ZV50
IERDMCTYCRKPLGV	SCEL	616	O95171
SKYECPICLMALREA	TRAF6	66	Q9Y4K3
VFCKEDLMVLCPLCT	TRIM75	106	A6NK02
HRYQMGCECKITRCP	TIMP2	146	P16035
ICFTMCCIYRPLKPR	TRPV6	381	Q9H1D0
DVFCYRMKDVNCTCK	STAB2	2286	Q8WWQ8
YQCIKCMVALFSSCP	USP9Y	2386	O00507
LCAVYMPKCENDRVE	SMO	126	Q99835
HPVCYRCSTKMRVLC	ZNF598	46	Q86UK7
RMCFVDPVRQCAECA	ZFYVE21	86	Q9BQ24
TMPAEAKTYRCRDCV	ZNF462	1361	Q96JM2
QPEKPCFRYRCMACL	TTC16	166	Q8NEE8
MADPEVCCFITKILC	ZC3HAV1	1	Q7Z2W4
MPKSCAARQCCNRYS	THAP3	1	Q8WTV1
SLMCEVCAFACKRKY	ZNF142	511	P52746
YRCHTIMNCTRTCPK	SDHB	241	P21912
EILNMEPYCCRETLK	USP44	596	Q9H0E7